-
1
-
-
10044247226
-
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers
-
Kennedy AS, Nutting C, Coldwell D, et al. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004;60:1552-63.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 1552-1563
-
-
Kennedy, A.S.1
Nutting, C.2
Coldwell, D.3
-
2
-
-
34247095550
-
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium
-
Kennedy A, Nag S, Salem R, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007;68:13-23.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.68
, pp. 13-23
-
-
Kennedy, A.1
Nag, S.2
Salem, R.3
-
3
-
-
77951478799
-
Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies
-
Kennedy AS, Salem R. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 2010;16:163-75.
-
(2010)
Cancer J
, vol.16
, pp. 163-175
-
-
Kennedy, A.S.1
Salem, R.2
-
5
-
-
27744592272
-
Liver metastases: incidence and histogenesis
-
Kasper HU, Drebber U, Dries V, et al. Liver metastases: incidence and histogenesis. Z Gastroenterol 2005;43:1149-57.
-
(2005)
Z Gastroenterol
, vol.43
, pp. 1149-1157
-
-
Kasper, H.U.1
Drebber, U.2
Dries, V.3
-
7
-
-
0034911117
-
Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience
-
Rose DM, Essne R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001;136:950-5.
-
(2001)
Arch Surg
, vol.136
, pp. 950-955
-
-
Rose, D.M.1
Essne, R.2
Hughes, T.M.3
-
8
-
-
33745360907
-
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women
-
Pentheroudakis G, Fountzilas G, Bafaloukos D, et al. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat 2006;97:237-44.
-
(2006)
Breast Cancer Res Treat
, vol.97
, pp. 237-244
-
-
Pentheroudakis, G.1
Fountzilas, G.2
Bafaloukos, D.3
-
9
-
-
0034911117
-
Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience
-
Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001;136:950-5.
-
(2001)
Arch Surg
, vol.136
, pp. 950-955
-
-
Rose, D.M.1
Essner, R.2
Hughes, T.M.3
-
10
-
-
33751321619
-
Is liver resection justified for patients with hepatic metastases from breast cancer?
-
discussion 907-8
-
Adam R, Aloia T, Krissat J, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006;244:897-907; discussion 907-8.
-
(2006)
Ann Surg
, vol.244
, pp. 897-907
-
-
Adam, R.1
Aloia, T.2
Krissat, J.3
-
11
-
-
34250021354
-
Epidemiology of colorectal liver metastases
-
McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007;16:3-5.
-
(2007)
Surg Oncol
, vol.16
, pp. 3-5
-
-
McMillan, D.C.1
McArdle, C.S.2
-
12
-
-
33645664218
-
A populationbased study of the incidence, management and prognosis of hepatic metastases from colorectal cancer
-
Leporrier J, Maurel J, Chiche L, et al. A populationbased study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006;93:465-74.
-
(2006)
Br J Surg
, vol.93
, pp. 465-474
-
-
Leporrier, J.1
Maurel, J.2
Chiche, L.3
-
13
-
-
0014654937
-
The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors
-
Ackerman NB, Lien WM, Kondi ES, et al. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 1969;66:1067-72.
-
(1969)
Surgery
, vol.66
, pp. 1067-1072
-
-
Ackerman, N.B.1
Lien, W.M.2
Kondi, E.S.3
-
14
-
-
0014833051
-
The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber
-
Lien WM, Ackerman NB. The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 1970;68:334-40.
-
(1970)
Surgery
, vol.68
, pp. 334-340
-
-
Lien, W.M.1
Ackerman, N.B.2
-
15
-
-
0015323129
-
The blood supply of experimental liver metastases. 3. The effects of acute ligation of the hepatic artery or portal vein
-
Ackerman NB, Lien WM, Silverman NA. The blood supply of experimental liver metastases. 3. The effects of acute ligation of the hepatic artery or portal vein. Surgery 1972;71:636-41.
-
(1972)
Surgery
, vol.71
, pp. 636-641
-
-
Ackerman, N.B.1
Lien, W.M.2
Silverman, N.A.3
-
16
-
-
0034076189
-
Mechanisms of angiogenesis and arteriogenesis
-
Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95.
-
(2000)
Nat Med
, vol.6
, pp. 389-395
-
-
Carmeliet, P.1
-
17
-
-
0016007951
-
Tumor angiogenesis
-
Folkman J. Tumor angiogenesis. Adv Cancer Res 1974;19:331-58.
-
(1974)
Adv Cancer Res
, vol.19
, pp. 331-358
-
-
Folkman, J.1
-
18
-
-
40849147041
-
EGFR antagonists in cancer treatment
-
Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008;358:1160-74.
-
(2008)
N Engl J Med
, vol.358
, pp. 1160-1174
-
-
Ciardiello, F.1
Tortora, G.2
-
19
-
-
14644440555
-
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
-
Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23:1011-27.
-
(2005)
J Clin Oncol
, vol.23
, pp. 1011-1027
-
-
Hicklin, D.J.1
Ellis, L.M.2
-
20
-
-
84863801928
-
Anti-angiogenesis therapies: their potential in cancer management
-
Eichholz A, Merchant S, Gaya AM. Anti-angiogenesis therapies: their potential in cancer management. Onco Targets Ther 2010;3:69-82.
-
(2010)
Onco Targets Ther
, vol.3
, pp. 69-82
-
-
Eichholz, A.1
Merchant, S.2
Gaya, A.M.3
-
21
-
-
84856265937
-
Radioembolization for the Treatment of Liver Tumors
-
Kennedy A, Coldwell D, Sangro B, et al. Radioembolization for the Treatment of Liver Tumors. Am J Clin Oncol 2012;35:91-9.
-
(2012)
Am J Clin Oncol
, vol.35
, pp. 91-99
-
-
Kennedy, A.1
Coldwell, D.2
Sangro, B.3
-
22
-
-
34548842842
-
Radioembolization with 90Y microspheres: angiographic and technical considerations
-
Lewandowski RJ, Sato KT, Atassi B, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007;30:571-92.
-
(2007)
Cardiovasc Intervent Radiol
, vol.30
, pp. 571-592
-
-
Lewandowski, R.J.1
Sato, K.T.2
Atassi, B.3
-
23
-
-
79958268563
-
General selection criteria of patients for radioembolization of liver tumors: an international working group report
-
Coldwell D, Sangro B, Wasan H, et al. General selection criteria of patients for radioembolization of liver tumors: an international working group report. Am J Clin Oncol 2011;34:337-41.
-
(2011)
Am J Clin Oncol
, vol.34
, pp. 337-341
-
-
Coldwell, D.1
Sangro, B.2
Wasan, H.3
-
24
-
-
84856304395
-
Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report
-
Kennedy A, Coldwell D, Sangro B, et al. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report. Am J Clin Oncol 2012;35:81-90.
-
(2012)
Am J Clin Oncol
, vol.35
, pp. 81-90
-
-
Kennedy, A.1
Coldwell, D.2
Sangro, B.3
-
25
-
-
77952008886
-
Computer modeling of controlled microsphere release and targeting in a representative hepatic artery system
-
Basciano CA, Kleinstreuer C, Kennedy AS, et al. Computer modeling of controlled microsphere release and targeting in a representative hepatic artery system. Ann Biomed Eng 2010;38:1862-79.
-
(2010)
Ann Biomed Eng
, vol.38
, pp. 1862-1879
-
-
Basciano, C.A.1
Kleinstreuer, C.2
Kennedy, A.S.3
-
26
-
-
73649120614
-
Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes
-
Kennedy AS, Kleinstreuer C, Basciano CA, et al. Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes. Int J Radiat Oncol Biol Phys 2010;76:631-7.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.76
, pp. 631-637
-
-
Kennedy, A.S.1
Kleinstreuer, C.2
Basciano, C.A.3
-
27
-
-
84858825507
-
Computational fluid dynamics modeling of 90Y microspheres in human hepatic tumors
-
Basciano CA, Kleinstreuer C, Kennedy AS. Computational fluid dynamics modeling of 90Y microspheres in human hepatic tumors. J Nucl Med Radiat Ther 2011;2:1.
-
(2011)
J Nucl Med Radiat Ther
, vol.2
, pp. 1
-
-
Basciano, C.A.1
Kleinstreuer, C.2
Kennedy, A.S.3
-
28
-
-
84859398928
-
Patient specific 3D image-based radiation dose estimates for 90y microsphere hepatic radioembolization in metastatic tumors
-
Kennedy A, Dezarn W, Weiss A. Patient specific 3D image-based radiation dose estimates for 90y microsphere hepatic radioembolization in metastatic tumors. J Nucl Med Radiat Ther 2011;2:1.
-
(2011)
J Nucl Med Radiat Ther
, vol.2
, pp. 1
-
-
Kennedy, A.1
Dezarn, W.2
Weiss, A.3
-
29
-
-
84881059437
-
Detecting distance between injected microspheres and target tumor via 3D reconstruction of tissue sections
-
Carson JP, Kuprat AP, Colby SM, et al. Detecting distance between injected microspheres and target tumor via 3D reconstruction of tissue sections. Conf Proc IEEE Eng Med Biol Soc 2012;2012:1149-52.
-
(2012)
Conf Proc IEEE Eng Med Biol Soc
, vol.2012
, pp. 1149-1152
-
-
Carson, J.P.1
Kuprat, A.P.2
Colby, S.M.3
-
30
-
-
65449163773
-
Radiologicpathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres
-
Riaz A, Kulik L, Lewandowski RJ, et al. Radiologicpathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 2009;49:1185-93.
-
(2009)
Hepatology
, vol.49
, pp. 1185-1193
-
-
Riaz, A.1
Kulik, L.2
Lewandowski, R.J.3
-
31
-
-
0032717571
-
Can current models explain the lack of liver complications in Y-90 microsphere therapy?
-
Yorke ED, Jackson A, Fox RA, et al. Can current models explain the lack of liver complications in Y-90 microsphere therapy? Clin Cancer Res 1999;5:3024s-30s.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 3024s-3030s
-
-
Yorke, E.D.1
Jackson, A.2
Fox, R.A.3
-
32
-
-
53649097821
-
Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment
-
Cremonesi M, Ferrari M, Bartolomei M, et al. Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment. Eur J Nucl Med Mol Imaging 2008;35:2088-96.
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 2088-2096
-
-
Cremonesi, M.1
Ferrari, M.2
Bartolomei, M.3
-
33
-
-
79961045223
-
Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies
-
Dezarn WA, Cessna JT, DeWerd LA, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 2011;38:4824.
-
(2011)
Med Phys
, vol.38
, pp. 4824
-
-
Dezarn, W.A.1
Cessna, J.T.2
DeWerd, L.A.3
-
34
-
-
67749094844
-
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors
-
Kennedy AS, McNeillie P, Dezarn WA, et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 2009;74:1494-500.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 1494-1500
-
-
Kennedy, A.S.1
McNeillie, P.2
Dezarn, W.A.3
-
35
-
-
83955163009
-
Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres
-
Lau WY, Kennedy AS, Kim YH, et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys 2012;82:401-7.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
, pp. 401-407
-
-
Lau, W.Y.1
Kennedy, A.S.2
Kim, Y.H.3
-
36
-
-
55249090678
-
Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution
-
Salem R, Parikh P, Atassi B, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol 2008;31:431-8.
-
(2008)
Am J Clin Oncol
, vol.31
, pp. 431-438
-
-
Salem, R.1
Parikh, P.2
Atassi, B.3
-
37
-
-
84995771351
-
Pre-90Y hepatic radiotherapy hemoglobin and liver functions to predict overall survival in unresectable, chemotherapyrefractory metastatic colorectal cancer
-
abstr 292.
-
Kennedy AS, Ball D, Cohen SJ, et al. Pre-90Y hepatic radiotherapy hemoglobin and liver functions to predict overall survival in unresectable, chemotherapyrefractory metastatic colorectal cancer. J Clin Oncol 2014;32:abstr 292.
-
(2014)
J Clin Oncol
, vol.32
-
-
Kennedy, A.S.1
Ball, D.2
Cohen, S.J.3
-
38
-
-
84995769056
-
Safety and efficacy of 90y resin microspheres in elderly (=70 years) compared to younger patients with colorectal liver metastases (mCRC)
-
abstr e14545.
-
Kennedy AS, Ball D, Cohen SJ, et al. Safety and efficacy of 90y resin microspheres in elderly (=70 years) compared to younger patients with colorectal liver metastases (mCRC). J Clin Oncol 2013;31:abstr e14545.
-
(2013)
J Clin Oncol
, vol.31
-
-
Kennedy, A.S.1
Ball, D.2
Cohen, S.J.3
-
39
-
-
84971262681
-
Hepatic imaging response to 90Y-microsphere therapy administered for tumor progression during systemic chemotherapy in patients with colorectal liver metastases
-
abstr 270.
-
Kennedy AS, Ball D, Cohen SJ, et al. Hepatic imaging response to 90Y-microsphere therapy administered for tumor progression during systemic chemotherapy in patients with colorectal liver metastases. J Clin Oncol 2013;30:abstr 270.
-
(2013)
J Clin Oncol
, vol.30
-
-
Kennedy, A.S.1
Ball, D.2
Cohen, S.J.3
-
40
-
-
84906094858
-
U.S. patients receiving resin 90Y microspheres for unresectable colorectal liver metastases: A multicenter study of 506 patients
-
abstr 3590.
-
Kennedy AS, Ball D, Cohen SJ, et al. U.S. patients receiving resin 90Y microspheres for unresectable colorectal liver metastases: A multicenter study of 506 patients. J Clin Oncol 2012;30:abstr 3590.
-
(2012)
J Clin Oncol
, vol.30
-
-
Kennedy, A.S.1
Ball, D.2
Cohen, S.J.3
-
41
-
-
65649154488
-
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres
-
Mulcahy MF, Lewandowski RJ, Ibrahim SM, et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009;115:1849-58.
-
(2009)
Cancer
, vol.115
, pp. 1849-1858
-
-
Mulcahy, M.F.1
Lewandowski, R.J.2
Ibrahim, S.M.3
-
42
-
-
77954087107
-
Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomographyguided high-dose-rate brachytherapy
-
Ricke J, Mohnike K, Pech M, et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomographyguided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2010;78:479-85.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.78
, pp. 479-485
-
-
Ricke, J.1
Mohnike, K.2
Pech, M.3
-
43
-
-
0035700227
-
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
-
Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001;12:1711-20.
-
(2001)
Ann Oncol
, vol.12
, pp. 1711-1720
-
-
Gray, B.1
Van Hazel, G.2
Hope, M.3
-
44
-
-
34047208542
-
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy
-
Sharma RA, Van Hazel GA, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25:1099-106.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1099-1106
-
-
Sharma, R.A.1
Van Hazel, G.A.2
Morgan, B.3
-
45
-
-
40649100263
-
FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer
-
Sharma RA, Wasan HS, Love SB, et al. FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer. Clin Oncol (R Coll Radiol) 2008;20:261-3.
-
(2008)
Clin Oncol (R Coll Radiol)
, vol.20
, pp. 261-263
-
-
Sharma, R.A.1
Wasan, H.S.2
Love, S.B.3
-
46
-
-
70249127628
-
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy
-
van Hazel GA, Pavlakis N, Goldstein D, et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 2009;27:4089-95.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4089-4095
-
-
van Hazel, G.A.1
Pavlakis, N.2
Goldstein, D.3
-
47
-
-
27644528184
-
A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIRspheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy
-
Lim L, Gibbs P, Yip D, et al. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIRspheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. BMC Cancer 2005;5:132.
-
(2005)
BMC Cancer
, vol.5
, pp. 132
-
-
Lim, L.1
Gibbs, P.2
Yip, D.3
-
48
-
-
77957266593
-
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
-
Hendlisz A, Van den Eynde M, Peeters M, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol 2010;28:3687-94.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3687-3694
-
-
Hendlisz, A.1
Van den Eynde, M.2
Peeters, M.3
-
49
-
-
77955058493
-
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
-
Cosimelli M, Golfieri R, Cagol PP, et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer 2010;103:324-31.
-
(2010)
Br J Cancer
, vol.103
, pp. 324-331
-
-
Cosimelli, M.1
Golfieri, R.2
Cagol, P.P.3
-
50
-
-
85014416567
-
Safety and efficacy of resin 90y-microspheres in 548 patients with colorectal liver metastases progressing on systemic chemotherapy
-
abstr 264.
-
Kennedy AS, Ball D, Cohen SJ, et al. Safety and efficacy of resin 90y-microspheres in 548 patients with colorectal liver metastases progressing on systemic chemotherapy. J Clin Oncol 2012;30:abstr 264.
-
(2012)
J Clin Oncol
, vol.30
-
-
Kennedy, A.S.1
Ball, D.2
Cohen, S.J.3
-
51
-
-
84995769056
-
Safety and efficacy of 90Y resin microspheres in elderly (=70 years) compared to younger patients with colorectal liver metastases (mCRC)
-
abstr e14545.
-
Kennedy A, Ball D, Cohen S, et al. Safety and efficacy of 90Y resin microspheres in elderly (=70 years) compared to younger patients with colorectal liver metastases (mCRC). J Clin Oncol 2013;31:abstr e14545.
-
(2013)
J Clin Oncol
, vol.31
-
-
Kennedy, A.1
Ball, D.2
Cohen, S.3
-
52
-
-
84942830612
-
Radiation oncology approaches in liver malignancies
-
Kennedy AS. Radiation oncology approaches in liver malignancies. Am Soc Clin Oncol Educ Book 2014;34:e150-5.
-
(2014)
Am Soc Clin Oncol Educ Book
, vol.34
, pp. e150-e155
-
-
Kennedy, A.S.1
-
53
-
-
33646237122
-
Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience
-
Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006;65:412-25.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 412-425
-
-
Kennedy, A.S.1
Coldwell, D.2
Nutting, C.3
-
54
-
-
84855352348
-
Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients
-
Bester L, Meteling B, Pocock N, et al. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J Vasc Interv Radiol 2012;23:96-105.
-
(2012)
J Vasc Interv Radiol
, vol.23
, pp. 96-105
-
-
Bester, L.1
Meteling, B.2
Pocock, N.3
-
55
-
-
84867532049
-
Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases
-
Seidensticker R, Denecke T, Kraus P, et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases. Cardiovasc Intervent Radiol 2012;35:1066-73.
-
(2012)
Cardiovasc Intervent Radiol
, vol.35
, pp. 1066-1073
-
-
Seidensticker, R.1
Denecke, T.2
Kraus, P.3
-
56
-
-
48949115121
-
Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases
-
Jakobs TF, Hoffmann RT, Dehm K, et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 2008;19:1187-95.
-
(2008)
J Vasc Interv Radiol
, vol.19
, pp. 1187-1195
-
-
Jakobs, T.F.1
Hoffmann, R.T.2
Dehm, K.3
-
57
-
-
33746616391
-
Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients
-
Stubbs RS, O'Brien I, Correia MM. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg 2006;76:696-703.
-
(2006)
ANZ J Surg
, vol.76
, pp. 696-703
-
-
Stubbs, R.S.1
O'Brien, I.2
Correia, M.M.3
-
58
-
-
78049487253
-
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival
-
Hilgard P, Hamami M, Fouly AE, et al. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 2010;52:1741-9.
-
(2010)
Hepatology
, vol.52
, pp. 1741-1749
-
-
Hilgard, P.1
Hamami, M.2
Fouly, A.E.3
-
59
-
-
77955711107
-
Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis
-
Iñarrairaegui M, Thurston KG, Bilbao JI, et al. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 2010;21:1205-12.
-
(2010)
J Vasc Interv Radiol
, vol.21
, pp. 1205-1212
-
-
Iñarrairaegui, M.1
Thurston, K.G.2
Bilbao, J.I.3
-
60
-
-
84876743410
-
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study
-
Mazzaferro V, Sposito C, Bhoori S, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology 2013;57:1826-37.
-
(2013)
Hepatology
, vol.57
, pp. 1826-1837
-
-
Mazzaferro, V.1
Sposito, C.2
Bhoori, S.3
-
61
-
-
72249087123
-
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of longterm outcomes
-
Salem R, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of longterm outcomes. Gastroenterology 2010;138:52-64.
-
(2010)
Gastroenterology
, vol.138
, pp. 52-64
-
-
Salem, R.1
Lewandowski, R.J.2
Mulcahy, M.F.3
-
62
-
-
80052023374
-
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation
-
Sangro B, Carpanese L, Cianni R, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology 2011;54:868-78.
-
(2011)
Hepatology
, vol.54
, pp. 868-878
-
-
Sangro, B.1
Carpanese, L.2
Cianni, R.3
-
63
-
-
79952039170
-
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization
-
Raoul JL, Sangro B, Forner A, et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 2011;37:212-20.
-
(2011)
Cancer Treat Rev
, vol.37
, pp. 212-220
-
-
Raoul, J.L.1
Sangro, B.2
Forner, A.3
-
64
-
-
74949126350
-
A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma
-
D'Avola D, Lnarrairaegui M, Bilbao JI, et al. A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma. Hepatogastroenterology 2009;56:1683-8.
-
(2009)
Hepatogastroenterology
, vol.56
, pp. 1683-1688
-
-
D'Avola, D.1
Lnarrairaegui, M.2
Bilbao, J.I.3
-
65
-
-
84866391058
-
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial
-
Bruix J, Raoul JL, Sherman M, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol 2012;57:821-9.
-
(2012)
J Hepatol
, vol.57
, pp. 821-829
-
-
Bruix, J.1
Raoul, J.L.2
Sherman, M.3
-
66
-
-
67650738915
-
Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings
-
Bilbao JI, de Martino A, de Luis E, et al. Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 2009;32:727-36.
-
(2009)
Cardiovasc Intervent Radiol
, vol.32
, pp. 727-736
-
-
Bilbao, J.I.1
de Martino, A.2
de Luis, E.3
-
67
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-90.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
-
68
-
-
57749189578
-
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
-
Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009;10:25-34.
-
(2009)
Lancet Oncol
, vol.10
, pp. 25-34
-
-
Cheng, A.L.1
Kang, Y.K.2
Chen, Z.3
-
69
-
-
77955505767
-
Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma
-
Iñarrairaegui M, Martinez-Cuesta A, Rodri´guez M, et al. Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2010;77:1441-8.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.77
, pp. 1441-1448
-
-
Iñarrairaegui, M.1
Martinez-Cuesta, A.2
Rodri´guez, M.3
-
70
-
-
38649127852
-
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
-
Kulik LM, Carr BI, Mulcahy MF, et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 2008;47:71-81.
-
(2008)
Hepatology
, vol.47
, pp. 71-81
-
-
Kulik, L.M.1
Carr, B.I.2
Mulcahy, M.F.3
-
71
-
-
84888303493
-
Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives
-
Salem R, Mazzaferro V, Sangro B. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives. Hepatology 2013;58:2188-97.
-
(2013)
Hepatology
, vol.58
, pp. 2188-2197
-
-
Salem, R.1
Mazzaferro, V.2
Sangro, B.3
-
72
-
-
79251575901
-
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma
-
Salem R, Lewandowski RJ, Kulik L, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011;140:497-507.e2.
-
(2011)
Gastroenterology
, vol.140
, pp. 497-507+e2
-
-
Salem, R.1
Lewandowski, R.J.2
Kulik, L.3
-
73
-
-
55149117758
-
Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation
-
Heckman JT, Devera MB, Marsh JW, et al. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol 2008;15:3169-77.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 3169-3177
-
-
Heckman, J.T.1
Devera, M.B.2
Marsh, J.W.3
-
74
-
-
67650938388
-
A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization
-
Lewandowski RJ, Kulik LM, Riaz A, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009;9:1920-8.
-
(2009)
Am J Transplant
, vol.9
, pp. 1920-1928
-
-
Lewandowski, R.J.1
Kulik, L.M.2
Riaz, A.3
-
75
-
-
67349204787
-
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization
-
Gaba RC, Lewandowski RJ, Kulik LM, et al. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 2009;16:1587-96.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 1587-1596
-
-
Gaba, R.C.1
Lewandowski, R.J.2
Kulik, L.M.3
-
76
-
-
84862171820
-
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma
-
Iñarrairaegui M, Pardo F, Bilbao JI, et al. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 2012;38:594-601.
-
(2012)
Eur J Surg Oncol
, vol.38
, pp. 594-601
-
-
Iñarrairaegui, M.1
Pardo, F.2
Bilbao, J.I.3
-
77
-
-
0028783988
-
Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors
-
Leung TW, Lau WY, Ho SK, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995;33:919-24.
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.33
, pp. 919-924
-
-
Leung, T.W.1
Lau, W.Y.2
Ho, S.K.3
-
78
-
-
2442680770
-
Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients
-
Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004;10:S107-10.
-
(2004)
Liver Transpl
, vol.10
, pp. S107-S110
-
-
Carr, B.I.1
-
79
-
-
34249066431
-
Gastroduodenal injury after radioembolization of hepatic tumors
-
Carretero C, Munoz-Navas M, Betes M, et al. Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 2007;102:1216-20.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1216-1220
-
-
Carretero, C.1
Munoz-Navas, M.2
Betes, M.3
-
80
-
-
7044231876
-
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma
-
Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004;127:S194-205.
-
(2004)
Gastroenterology
, vol.127
, pp. S194-205
-
-
Geschwind, J.F.1
Salem, R.2
Carr, B.I.3
-
81
-
-
33646102404
-
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival
-
Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005;16:1627-39.
-
(2005)
J Vasc Interv Radiol
, vol.16
, pp. 1627-1639
-
-
Salem, R.1
Lewandowski, R.J.2
Atassi, B.3
-
82
-
-
60149084839
-
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
-
Woodall CE, Scoggins CR, Ellis SF, et al. Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? J Am Coll Surg 2009;208:375-82.
-
(2009)
J Am Coll Surg
, vol.208
, pp. 375-382
-
-
Woodall, C.E.1
Scoggins, C.R.2
Ellis, S.F.3
-
83
-
-
84874478395
-
Prognostic factors and prevention of radioembolizationinduced liver disease
-
Gil-Alzugaray B, Chopitea A, Inarrairaegui M, et al. Prognostic factors and prevention of radioembolizationinduced liver disease. Hepatology 2013;57:1078-87.
-
(2013)
Hepatology
, vol.57
, pp. 1078-1087
-
-
Gil-Alzugaray, B.1
Chopitea, A.2
Inarrairaegui, M.3
-
84
-
-
44949120870
-
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients
-
Kennedy AS, Dezarn WA, McNeillie P, et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 2008;31:271-9.
-
(2008)
Am J Clin Oncol
, vol.31
, pp. 271-279
-
-
Kennedy, A.S.1
Dezarn, W.A.2
McNeillie, P.3
-
85
-
-
52049109269
-
Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
-
King J, Quinn R, Glenn DM, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008;113:921-9.
-
(2008)
Cancer
, vol.113
, pp. 921-929
-
-
King, J.1
Quinn, R.2
Glenn, D.M.3
-
86
-
-
44449085489
-
90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience
-
Rhee TK, Lewandowski RJ, Liu DM, et al. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 2008;247:1029-35.
-
(2008)
Ann Surg
, vol.247
, pp. 1029-1035
-
-
Rhee, T.K.1
Lewandowski, R.J.2
Liu, D.M.3
-
87
-
-
77949347750
-
Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases
-
Cao CQ, Yan TD, Bester L, et al. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg 2010;97:537-43.
-
(2010)
Br J Surg
, vol.97
, pp. 537-543
-
-
Cao, C.Q.1
Yan, T.D.2
Bester, L.3
-
88
-
-
77951666352
-
Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases
-
Saxena A, Chua TC, Bester L, et al. Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases. Ann Surg 2010;251:910-6.
-
(2010)
Ann Surg
, vol.251
, pp. 910-916
-
-
Saxena, A.1
Chua, T.C.2
Bester, L.3
-
89
-
-
84861635890
-
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes
-
Memon K, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys 2012;83:887-94.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.83
, pp. 887-894
-
-
Memon, K.1
Lewandowski, R.J.2
Mulcahy, M.F.3
-
90
-
-
84862896097
-
Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres
-
Paprottka PM, Hoffmann RT, Haug A, et al. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres. Cardiovasc Intervent Radiol 2012;35:334-42.
-
(2012)
Cardiovasc Intervent Radiol
, vol.35
, pp. 334-342
-
-
Paprottka, P.M.1
Hoffmann, R.T.2
Haug, A.3
-
91
-
-
84867864032
-
Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases -a systematic review
-
Yang TX, Chua TC, Morris DL. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases -a systematic review. Surg Oncol 2012;21:299-308.
-
(2012)
Surg Oncol
, vol.21
, pp. 299-308
-
-
Yang, T.X.1
Chua, T.C.2
Morris, D.L.3
-
92
-
-
84857838286
-
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary
-
Pavel M, Baudin E, Couvelard A, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2012;95:157-76.
-
(2012)
Neuroendocrinology
, vol.95
, pp. 157-176
-
-
Pavel, M.1
Baudin, E.2
Couvelard, A.3
-
93
-
-
84891369262
-
Recommendations for management of patients with neuroendocrine liver metastases
-
Frilling A, Modlin IM, Kidd M, et al. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol 2014;15:e8-e21.
-
(2014)
Lancet Oncol
, vol.15
, pp. e8-e21
-
-
Frilling, A.1
Modlin, I.M.2
Kidd, M.3
-
94
-
-
84995813540
-
Role of hepatic intra-arterial therapies in metastatic neuroendocrine (net) carcinomas: Guidelines from NET-Liver-Metastases Consensus Conference
-
[Epub ahead of print].
-
Kennedy A, Bester L, Salem R, et al. Role of hepatic intra-arterial therapies in metastatic neuroendocrine (net) carcinomas: Guidelines from NET-Liver-Metastases Consensus Conference. HPB: The official journal of the International Hepato Pancreato Biliary Association 2014. [Epub ahead of print].
-
(2014)
HPB: The official journal of the International Hepato Pancreato Biliary Association
-
-
Kennedy, A.1
Bester, L.2
Salem, R.3
|